Scientific collaboration network: Through our collaboration programs we continuously expand the scope of our technology and validate it in new therapeutic areas. 17 partners are collaborating with us on PSM related research that has so far resulted in 13 publications in leading journals with additional publications in the pipeline.
Pharma collaborations: In parallel to running our in-house programs, Anima has strategically structured itself to collaborate with pharma partners on their existing or new programs. Our technology platform provides our partners with a new strategy to approach hard and "undruggable" targets in a wide range of indications. In this collaboration model, we combine the power of our technology platform with the pre-clinical, clinical and financial capabilities of a pharma partner t build a long term partnership around one or more drug discovery programs in their area of interest.